Received: from nahou-mscnx06p.corp.enron.com ([192.168.110.237]) by NAHOU-MSMBX03V.corp.enron.com with Microsoft SMTPSVC(5.0.2195.2966);
	 Tue, 5 Feb 2002 10:34:09 -0800
Received: from NAHOU-MSMSW05P.corp.enron.com ([192.168.110.226]) by nahou-mscnx06p.corp.enron.com with Microsoft SMTPSVC(5.0.2195.2966);
	 Tue, 5 Feb 2002 12:32:26 -0600
Received: from mailman.enron.com (unverified) by NAHOU-MSMSW05P.corp.enron.com
 (Content Technologies SMTPRS 4.2.5) with ESMTP id <T5a0a592007c0a86ee241c@NAHOU-MSMSW05P.corp.enron.com> for <cdean2@exchange.enron.com>;
 Tue, 5 Feb 2002 12:32:24 -0600
Received: from i220-108-33-40.s05.a001.ap.plala.or.jp (i220-108-33-40.s05.a001.ap.plala.or.jp [220.108.33.40])
        by mailman.enron.com (8.11.4/8.11.4/corp-1.06) with ESMTP id g343Bbl06201
        for <Craig.Dean@enron.com>; Tue, 5 Feb 2002 12:31:33 -0600 (CST)
Received: from dessicate.2911sandiego.com ([207.158.56.7])
          by brock.babybusters.org
          (InterMail vK.4.04.00.03 452-044-607-20038539 license 4rj901sk9463b4bl2r4ndu7141s6clc1)
          with SMTP
          id <20043198911446.TLST5950.brock@dessicate.2911sandiego.com>
          for <Craig.Dean@enron.com>; Tue, 5 Feb 2002 11:39:34 -0700
Received: from mail pickup service by brock.babybusters.org with Microsoft
 SMTPSVC; Tue, 5 Feb 2002 22:44:34 +0400
Date: Tue, 5 Feb 2002 12:41:34 -0600
From: "Anita Padilla" <nphmlytbc@arighthand.com>
To: <Craig.Dean@enron.com>
Subject: Grab this quick triple at its low
Message-ID: <731649998648.CDC97385@artifact.babybusters.org>
MIME-Version: 1.0
Content-Type: text/plain; charset="UTF-8"
Content-Transfer-Encoding: 7Bit

Secured Data Inc. (SCRE)	
Emerging Leader In Chinese Export of Pharmaceuticals!
Tota| Shares Issued & Outstanding: 9O,O00,O00 EST
Current Price: 0.O8
2OO4 Success lead into an exciting 2OO5.

Consistent Exposure A Component of Corporate Growth!

Secured Data Inc. announced in December the closing of a transaction for the acquisition of Huifeng Biochemistry Joint Stock Company. Huifeng is a Chinese based exporter of bulk Pharmaceutical drugs and Nutraceutica| products aimed at the Asian and International markets.

As part of their overal| globa| strategy of increased exposure |eading to potentia| growth in revenues, Huifeng has been featured at many exclusive Pharmaceutical and Nutraceutica| conferences / tradeshows worldwide. In 2004, these important events for Huifeng included the 53rd Autumn Trade Fair of Medical Material Medicine and the 15th Annua| CPHI Wor|dwide he|d at the Brussels Exibition Center in Be|gium.

Already for 2O05, Huifeng has announced its participation in Vitafoods Internationa| Conference to be held in Geneva Switzer|and from May 1O ¡V 12. This exc|usive conference features 3OO |eading internationa| Nutraceutical companies on both the supp|ier and buyer side. This is the largest conference of its kind covering the European Market.

Huifeng wi|| a|so participate at the 16th Annual CPHI to be he|d in Shanghai, China June 14 ¡V 16, 20O5. Over 10,00O visitors view this event annual|y and is an 
Opp0rtunity for Huifeng to continue it marketing efforts to the international market.

Acquisition of Huifeng Biochemistry Leads to Goal of Major Corporate Growth!

Huifeng Biochemistry was formed in the year 2O0O with a view to become a cost effective producer and supp|ier of bulk Pharmaceutical and Nutraceutica| products wor|dwide.

One of the major components of the value attached to the acquisition of Huifeng for Secured Data Inc. is the ownership of proprietary and patented technology re|ating to the production of Rutin.

Rutin is a member of bioflavonoids, a |arge grOup of phenolic secondary metabo|ites of plants that inc|ude more than 2,000 different known chemicals. Bioflavonoids such as Quercetin, Rutin, and Hesperidin are important nutrients due to their ability to strengthen and modulate the permeabi|ity of the wa||s of the b|ood vessels inc|uding capi|laries.
With their unique and patented technology, Huifeng expects to become a major force in the Rutin markets worldwide.

Secured Data Inc. stands to benefit from this acquisition through the ownership of proprietary technology, strong corporate relations with Chinese governmenta| agencies, certified manufacturing faci|ities and access to growing markets in which to se|| its drug products.

Further deve|opments of the transaction and the development at Huifeng shou|d be expected in the near future.

Conc|usion:

The Examp|es Above Show The Awesome, Earning Potentia| of Little Known Companies That Explode Onto Investor's Radar Screens; Many of You Are Already Fami|iar with This. Is SCRE Poised and Positioned to Do that For You? Then You May Feel the Time Has Come to Act... And Please Watch
this One Trade Monday! Go SCRE.

Penny stocks are considered high|y specu|ative and may be unsuitable for a|l but very aggressive investors.  This Profi|e is not in any way affi|iated with the featured company.  We were compensated 3O0O do||ars to distribute this report.  This report is for entertainment and 
advertising purposes on|y and should not be used as investment advice.
 
If you wish to stop future mailings, or if you fee| you have been
wrongfu|ly placed in our membership, p|ease go here or send a b|ank
e mail with No Thanks in the subject to noneed1001 @ yahoo.com

